Liabilities, Current of NexImmune, Inc. from 31 Dec 2020 to 30 Jun 2024

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: NexImmune, Inc. quarterly Liabilities, Current in USD history and change rate from 31 Dec 2020 to 30 Jun 2024.
NexImmune, Inc. Liabilities, Current for the quarter ending 30 Jun 2024 was $4,736,591, a 24% decline year-over-year.
Source SEC data: View on sec.gov

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Change (%)

NexImmune, Inc. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2024	$4,736,591	-$1,530,988	-24%	30 Jun 2024	10-Q	07 Aug 2024	2024	Q2
Q1 2024	$4,634,308	-$2,151,852	-32%	31 Mar 2024	10-Q	20 May 2024	2024	Q1
Q4 2023	$5,084,232	-$5,249,342	-51%	31 Dec 2023	10-Q	07 Aug 2024	2024	Q2
Q3 2023	$6,204,679	-$3,189,731	-34%	30 Sep 2023	10-Q	17 Nov 2023	2023	Q3
Q2 2023	$6,267,579	-$2,846,208	-31%	30 Jun 2023	10-Q	10 Aug 2023	2023	Q2
Q1 2023	$6,786,160	-$305,175	-4.3%	31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q4 2022	$10,333,574	+$3,117,706	+43%	31 Dec 2022	10-K	16 Apr 2024	2023	FY
Q3 2022	$9,394,410	+$1,961,863	+26%	30 Sep 2022	10-Q	14 Nov 2022	2022	Q3
Q2 2022	$9,113,787	+$3,630,566	+66%	30 Jun 2022	10-Q	15 Aug 2022	2022	Q2
Q1 2022	$7,091,335	+$998,181	+16%	31 Mar 2022	10-Q	12 May 2022	2022	Q1
Q4 2021	$7,215,868	-$19,810,930	-73%	31 Dec 2021	10-K	28 Mar 2023	2022	FY
Q3 2021	$7,432,547			30 Sep 2021	10-Q	12 Nov 2021	2021	Q3
Q2 2021	$5,483,221			30 Jun 2021	10-Q	09 Aug 2021	2021	Q2
Q1 2021	$6,093,154			31 Mar 2021	10-Q	17 May 2021	2021	Q1
Q4 2020	$27,026,798			31 Dec 2020	10-K	09 Mar 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.